home All News open_in_new Full Article

Novo bets on 'triple G' obesity drug in up to $2 billion deal with Chinese biotech

Novo bets on 'triple G' obesity drug in up to $2 billion deal with Chinese biotech  Reuters


today 4 d. ago attach_file Economics

attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Events
attach_file Events
attach_file Society


ID: 930587501
Add Watch Country

arrow_drop_down